Potentiated Therapeutic Angiogenesis by Primed Human mesenchymal Stem Cells in a Mouse Model of Hindlimb Ischemia | Zendy

Eun Ju Lee | Zendy; HwanWoo Park | Zendy; Hyo-Jin Jeon | Zendy; HyoSoo Kim | Zendy; MiSook Chang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Potentiated Therapeutic Angiogenesis by Primed Human mesenchymal Stem Cells in a Mouse Model of Hindlimb Ischemia

Author(s) -

Eun Ju Lee,

HwanWoo Park,

Hyo-Jin Jeon,

HyoSoo Kim,

MiSook Chang

Publication year - 2013

Publication title -

regenerative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.572

H-Index - 63

eISSN - 1746-076X

pISSN - 1746-0751

DOI - 10.2217/rme.13.17

Subject(s) - mesenchymal stem cell , therapeutic angiogenesis , angiogenesis , paracrine signalling , transplantation , in vivo , cell therapy , medicine , cancer research , ischemia , priming (agriculture) , stem cell , immunology , neovascularization , microbiology and biotechnology , pathology , biology , botany , receptor , germination

Human bone marrow-derived mesenchymal stem cells (hMSCs) are advantageous for cell-based therapy to treat ischemic diseases owing to their capacity to secrete various paracrine factors with potent angiogenic activity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research